Earlier visibility of diversity data for earlier intervention

StudyTeam® is an innovative clinical trial solution that equips sponsors with diversity insights during enrollment.

Why is collecting diversity data early in the enrollment funnel important?

Per the FDA: “Clinical trials provide a crucial base of evidence for evaluating whether a medical product is safe and effective; therefore, enrollment in clinical trials should reflect the diversity of the population that is ultimately going to use the treatment.” Despite this, the majority of data collected on diversity and inclusion in clinical trials is either post-consent or post-randomization data. What that means: By the time you see you have missed your recruitment diversity goals, it is too late to take action.

Use StudyTeam to identify diversity and inclusion challenges in clinical trials — and take corrective action early

Sponsors who use StudyTeam gain access to earlier reporting of recruitment and enrollment metrics categorized by race and ethnicity. Accessing this data as early as pre-screening means that sponsors can take the necessary steps to intervene and adjust recruitment strategies while enrollment is still taking place.

How It Works

Capture diversity data early in the enrollment funnel.

Your sites easily capture and document race and ethnicity data right in StudyTeam for Sites while they are pre-screening potential participants. This ensures that race and ethnicity data is collected for every single patient – not just the ones who are ultimately enrolled in a trial.

Access reporting and insights.

You access comprehensive, de-identified reporting categorized by race and ethnicity within StudyTeam for Sponsors. These interactive reports allow you to evaluate diversity representation across the entire trial as well as at individual sites.

Enact change to meet diversity goals.

You can identify where patients are dropping out of the enrollment funnel and assess if there are any trends that may disproportionately affect certain populations. You can then take action to remove unnecessary restrictions or barriers that may exclude certain groups of patients from trial eligibility or enrollment.

Take a guided tour of StudyTeam's diversity reporting capabilities

Don't wait until after consent to evaluate if you met your diversity goals for enrollment. With StudyTeam for Sponsors, you can measure race and ethnicity metrics while your trial is still actively enrolling.